Does percutaneous coronary intervention reduce mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization compared to optimal medical therapy in patients with stable coronary artery disease?
In patients with stable coronary artery disease, PCI does not improve hard clinical outcomes compared to optimal medical therapy, though it may offer superior symptom relief.
In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.
Pursnani et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: